EUVIMEDEUVIMED entdecken
Crossref

Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient

Martyna Pociupany iD, Sarah Gillemot, Aspasia Georgala, Robert Snoeck, Graciela Andrei

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Martyna Pociupany und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Immunology and Transplantation, Molecular, Structural, and Translational Virology Research Group, Rega Institute for Medi…. Hauptthemen laut MEDLINE: Coinfection, Cytomegalovirus, Cytomegalovirus Infections, Drug Resistance, Viral. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Sciensano, Belgian Institute for Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Herpesvirus infections [e.g. Epstein–Barr virus (EBV) or cytomegalovirus (CMV)] are a major cause of mortality and morbidity in post-transplant patients despite antiviral therapy, with the emergence of drug resistance further complicating patients’ care.

Objectives

To evaluate the dynamics and drug resistance of simultaneous EBV and CMV reactivations in an HSCT recipient. Patients and methods Twenty-two samples derived from blood, one sample from bone marrow and one sample from colon biopsy over an 8 month period while under different anti-CMV treatments were analysed. CMV, EBV and torque teno virus (TTV) DNA loads were determined and viral dynamics were investigated by genotyping of the CMV and EBV genes involved in drug resistance by Sanger sequencing (prospectively) and next-generation sequencing (NGS) (retrospectively).

Results

EBV reactivation was seen simultaneously with CMV reactivation and rising of TTV DNA load, suggesting increased immunosuppression. A reduction of EBV viraemia under maribavir was observed. Emergence of the CMV DNA polymerase (DP) L773V MDR mutation occurred following antiviral treatment and was subsequently replaced by the CMV UL97 protein kinase (PK) ganciclovir resistance A594P mutation, which could be detected earlier by NGS than by Sanger sequencing. At 273 days post-transplantation, the patient still had active CMV/EBV co-reactivation, with CMV being refractory to antiviral therapy.

Conclusions

The use of NGS and Sanger sequencing revealed evolution of CMV drug resistance under antiviral treatment. Our findings highlight the potential of maribavir to treat EBV infection and the difficulties in managing CMV/EBV co-reactivation in immunocompromised hosts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CoinfectionCytomegalovirusCytomegalovirus InfectionsDrug Resistance, ViralEpstein-Barr Virus InfectionsHematopoietic Stem Cell TransplantationHerpesvirus 4, HumanHumansAntiviral AgentsDNA, ViralGenotypeHigh-Throughput Nucleotide SequencingTorque teno virusViral LoadVirus ActivationAged

Substanzen

Antiviral AgentsDNA, Viral

Autor:innen und Institutionen

  • Department of Microbiology, Immunology and Transplantation, Molecular, Structural, and Translational Virology Research Group, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
  • Infectious Diseases Department, Institut Jules Bordet - Université Libre de Bruxelles (ULB), Brussels, Belgium.

ORCID-Profile: Martyna Pociupany

Förderung

  • Sciensano
  • Belgian Institute for Health

Zitieren

APA

Pociupany, M., Gillemot, S., Georgala, A., Snoeck, R., & Andrei, G. (2025). Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf243

Vancouver

Pociupany M, Gillemot S, Georgala A, Snoeck R, Andrei G. Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf243

BibTeX
@article{Pociupany2025,
  author = {Pociupany, Martyna and Gillemot, Sarah and Georgala, Aspasia and Snoeck, Robert and Andrei, Graciela},
  title = {Dynamics of dual CMV and EBV co-reactivation and emergence of resistance in an HSCT recipient},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf243}
}
Kostenlos starten →